T

    TALMedora Editorial

    Hyderabad | Touch-A-Life Foundation

    3 months ago

    Ozempic Linked to 30% Lower Breast Cancer Risk, Real World…

    Ozempic Linked to 30% Lower Breast Cancer Risk, Real World Data is Hard to Ignore A large new study has found that GLP-1 drugs like semaglutide are associated with a 30% lower risk of breast cancer. This adds to a growing body of evidence that these drugs may have anti-cancer properties beyon

    Create an account to read the full story.

    Join TALMedora to get full access

    Already have an account?

    Comments (0)

    U

    No comments yet. Be the first to comment!